Study

EORTC-26981-22981

"Concomitant and adjuvant Temozolomide and Radiotherapy for newly diagnosed glioblastoma multiforme. A randomized phase III study"

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 24-Jul-2000
Date Step1 close: 22-Mar-2002

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 520

Treatment

Study Staff

Type of cancer

Participating groups

Protocol summary

http://clinicaltrials.gov/study/NCT00006353

NCT number

NCT00006353